Sun.Nov 27, 2022

article thumbnail

Answer of the Day for Nov 28, 2022


Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Yes. The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components.

article thumbnail

Cerity Partners LLC Acquires New Position in Aurora Cannabis Inc.

Cannabis Law Report

Cerity Partners LLC acquired a new stake in Aurora Cannabis Inc. (NYSE:ACB – Get Rating) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 45,358 shares of the company’s stock, valued at approximately $60,000. Other hedge funds and other institutional investors have also […].